Shelley Cragg Rozas, PA
Medical · Oklahoma City, OKNPI 1720161698
Payments from drug & device makers
Across 41 payments — averaging $19.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organogenesis Inc.$174
- Paratek Pharmaceuticals, Inc.$102
- Smith+Nephew$85
- Solventum Corporation$78
- Tactile Systems Technology Inc$64
- Bsn Medical Inc$60
- plus $221 from 10 others
What the payments were for
- Food & beverage$783100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organogenesis Inc. | 7 | $174 |
| Paratek Pharmaceuticals, Inc. | 6 | $102 |
| Smith+Nephew | 5 | $85 |
| Solventum Corporation | 4 | $78 |
| Tactile Systems Technology Inc | 4 | $64 |
| Bsn Medical Inc | 2 | $60 |
| KCI USA, Inc. | 2 | $31 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $27 |
| OVIK Health, LLC | 2 | $27 |
| Molnlycke Health Care US, LLC | 2 | $25 |
| Acera Surgical, Inc. | 1 | $22 |
| Nevro Corp. | 1 | $20 |
| Reapplix Inc. | 1 | $19 |
| Next Science LLC | 1 | $19 |
| Hydrofera LLC | 1 | $17 |
| Reprise Biomedical, Inc. | 1 | $14 |
How this compares
$783 in reported general payments places this provider in the 60th percentile of 370 medical providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Hyclate | 33 | $377 |
| Ciprofloxacin Hcl | 26 | $241 |
| Cefdinir | 13 | $205 |
| Cephalexin | 18 | $177 |
| Amoxicillin | 15 | $67 |
Paid to pharmacies, not to this prescriber.
Other medical in Oklahoma City
- Mebin ThomasOklahoma City$323K
- Kristine MurrowOklahoma City$81K
- Katelyn PuryearOklahoma City$22K
- Kelly WalworthOklahoma City$15K
- Jere ClaunchOklahoma City$15K
- Vy TranOklahoma City$15K
- Jennifer MinshallOklahoma City$11K
- Lindee LedbetterOklahoma City$10K
- Christina HelmsOklahoma City$7K
- John ParmeleeOklahoma City$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.